What I am working with: a quantified content assay · oral semaglutide.
I would like the axes of comparison first and the recommendation second.
I have tried the first option and it works; the question is whether the second is better rather than merely different.
What is the actual trade-off, and does it matter at the scale I am working at?
The part that matters: a high purity does not guarantee high content because it says nothing about how much of anything is in the vial — a vial could be 99 per cent pure but only half full.
Comparing content results from different laboratories requires knowing whether they both used certified reference materials or whether one used an in-house standard of unknown provenance.
| Δ mass (Da) | Most likely cause | Distinguishing feature |
|---|---|---|
| +1 | Deamidation (Asn or Gln) | New peak, slightly earlier retention |
| −17 | Loss of ammonia | Often with deamidation |
| −18 | Dehydration / succinimide | pH-dependent, reversible |
| +16 | Oxidation (Met, Trp) | Earlier retention, light-related |
| −128 | Missing Gln or Lys | Deletion sequence from synthesis |
| 0 | Isomer: racemisation or scrambling | Same mass, shifted retention |
The underlying point is that if the standard and sample have different absorption coefficients at the detection wavelength, the response factors differ and the inference fails.
The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.
Ask for both the purity and the content, and do not accept purity alone.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsWorth being precise here: content assay requires a reference standard of known purity and traceability, which is why it costs more than purity testing does.
Peak area for a standard of known weight produces a response factor — area per unit mass — which is then applied to the sample peak to infer sample mass.
Water content and counter-ion content are part of the gross mass but not part of the content assay result, which is why the two do not sum to label claim.
Quantitation against a standard requires that the standard be traceable to a national metrology institute, and certificates for research-grade standards claim that traceability.
If a supplier gives you content without the standard's purity, ask them to provide it.
The short answer is that purity says "what fraction of detected material is the target" while content says "how many milligrams of the target are present," and those are two different things.
System suitability for a quantitative method is stricter than for purity because a small systematic error in the standard directly translates into an error in the sample result.
Quantitation against a certified reference material assumes the sample and standard are treated identically through the analytical method, which is why the method for calibration matters as much as the method for measurement.
Worth noting that the standard certificate carries its own uncertainty, usually on the order of two to three per cent, which the sample result inherits.
The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.
edited 19 Sept 2025 by kwn_analytical — added the placebo-arm figures
Start from what you are trying to know — whether a vial contains what the label claims — and purity does not answer that question.
Running multiple independent aliquots of the same sample should give results that agree to within the method precision, which is usually one to three per cent.
Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.
The limitation is that a quantitative method is only as good as the standard it uses, and a cheap standard is a false economy.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
edited 20 Jun 2025 by tandem_gradient — added the method parameters
In practice, quantified content is how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard, and it is the only measurement that directly answers that question.
If a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.
Where content data have been published from testing services on common peptides, the spread between services on identical material is typically a few per cent.
One qualification: a single result from a single vial is a point estimate, and repeating the assay on a second aliquot is worth doing if the first result is surprising.
In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.